Sr. Machine Learning Researcher
AKASA- Full Time
- Senior (5 to 8 years)
Employment Type: Full-time
Genesis AI team is focused on developing foundation models for small molecule drug discovery. We conduct fundamental research at the intersection of machine learning, physics, and computational chemistry, and engineer robust software systems. These systems enable large-scale simulations and the training of generative and predictive AI models designed to learn from all kinds of molecular data, leveraging our cluster with thousands of GPUs and tens of thousands of CPUs.
We are a tight-knit team of proven drug hunters, deep learning researchers, and software engineers united by a common mission: to drive AI innovation in biochemistry and discover/develop groundbreaking therapies for patients suffering from severe disorders.
We are seeking experienced ML Research Engineers to join our team and lead research and engineering efforts focused on driving forward our ML research agenda for generative modeling of molecular systems, which is instrumental to our mission.
As an ML Research Engineer at Genesis, you will drive forward novel ML experimentation, ideation, execution, and analyses of results on the path towards building larger and more powerful generative and predictive models of biomolecular systems of increasing complexity. Blending techniques from cutting-edge machine learning (denoising diffusion, equivariant architectures, self-supervised training of multi-modal models, RL-based alignment) and computational physics/chemistry (molecular dynamics, quantum mechanics), you will lead rapid iteration on our AI platform, unlocking the next level of performance, efficiency, and scale that was not previously possible.
Genesis is a highly collaborative and cross-functional environment, and you will work in close partnership with our exceptional engineers, researchers, and biochemistry experts. Positions are available at various levels of seniority, starting from Senior and above.
AI-driven drug discovery for pharmaceuticals
Genesis Therapeutics accelerates the development of new medicines by using artificial intelligence in drug discovery. The company combines 3D spatial graph modeling and molecular simulation to identify potential drug candidates and explore new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The goal is to transform the drug discovery process and bring new therapies to market.